|
J Biol Chem, Vol. 274, Issue 53, 38140-38146, December 31, 1999
Rho Controls Cortical F-actin Disassembly in Addition to, but
Independently of, Secretion in Mast Cells*
Richard
Sullivan ,
Leo S.
Price§, and
Anna
Koffer¶
From the Physiology Department, University College London,
University Street, London WC1E 6JJ, United Kingdom
 |
ABSTRACT |
Localized disassembly of cortical F-actin has
long been considered necessary for facilitation of exocytosis. Exposure
of permeabilized mast cells to calcium/ATP induces cortical F-actin
disassembly (calmodulin-dependent) and secretion
(calmodulin-independent). The delay in the onset of secretion is
characteristic for the calcium/ATP response and is abolished by GTP.
Here we report that a constitutively active mutant of Rho (V14RhoA)
enhanced both secretion and cortical F-actin disassembly. In addition,
V14RhoA mimicked GTP by abolishing the delay in secretion. Inhibition of Rho by C3 transferase prevented both secretion (~80%) and F-actin disassembly (~20%). Thus, both Rho GTPase and calcium/calmodulin contribute to the control of cortical F-actin disassembly.
Stabilization of actin filaments by high concentrations of phalloidin
or by a calmodulin-inhibitory peptide (based on the calmodulin-binding domain of myosin light chain kinase) did not affect the extent of
secretion or the secretion-enhancing effects of V14RhoA. These results
further support the existence of divergent, Rho-dependent, pathways regulating actin and exocytosis. Furthermore, compound Y-27632, a specific inhibitor of Rho-associated protein kinase (p160ROCK), attenuated the Rho-induced loss of cortical F-actin
without affecting secretion. A model is presented in which Rho
regulates secretion and cortical F-actin in a manner dependent on
and/or synergistic with calcium.
 |
INTRODUCTION |
The plasma membrane of eukaryotic cells is supported by an actin
cortex, a network of actin filaments organized and regulated by a
variety of actin-binding proteins. Changes in the rigidity of the
cortical actin network constitute an important component of the
cellular response to receptor activation and require localized disassembly of cortical actin filaments. Signals from cell surface receptors to the cytoskeleton are often mediated by small GTP-binding proteins of the Rho family, e.g. RhoA, -B, -C, -D, -E, and
-G; Rac1 and -2; Cdc42; and TC10. Several targets for the members of
this family have been identified, including a number of serine threonine kinases (PKN, Rho kinase, p65PAK) and tyrosine
kinases (p120ACK, MLK3). In addition to cell morphology, Rho
GTPases control many other functions such as neuronal development, cell
cycle, and gene transcription (1-3). New evidence indicates
participation of Rho GTPases in the regulation of exocytosis,
endocytosis, and vesicular transport in general (4-9). To what extent
this is accomplished via regulation of actin is still unclear.
Cortical actin disassembly is particularly important for secreting
cells; cortical filaments have long been considered to act as a barrier
preventing the access of secretory granules to the plasma membrane
(10). Mast cells serve as a useful model for investigating the
relationship between cytoskeletal rearrangements and exocytosis (11).
Use of permeabilized cells allows control of the internal environment
and thus investigation of specific effects induced by ions,
nucleotides, or proteins. Such studies have established that calcium
and GTP, acting in synergy, induce high levels of secretion (12). With
respect to the cytoskeletal effects,
GTP S,1 a nonhydrolyzable
analogue of GTP, was found to induce a selective loss and increase of
F-actin in the cell cortex and interior, respectively. The former
effect is not significantly inhibited by a Rho-specific inhibitor, C3
transferase, while the latter is entirely dependent on the activity of
Rho (13). Secretion induced by calcium alone (i.e. in the
absence of added GTP/GTP S) is associated only with a profound loss
of the cortical F-actin (14). Thus, cortical F-actin disassembly is
induced by both calcium-dependent and -independent pathways.
In this paper, we have focused on the calcium-dependent
responses of permeabilized mast cells. Calcium-induced cortical F-actin disassembly requires calmodulin; it is promoted by the addition of
exogenous calmodulin and strongly inhibited by depletion of the
endogenous calmodulin. None of these effects, however, are accompanied
by changes in the secretory responses. The main target for calmodulin
is myosin light chain kinase; its inhibitor, ML-7, prevents cortical
disassembly, again without effects on
secretion.2 Thus, myosin
II-based contractility, activated by calcium-calmodulin, may be a
prerequisite for cortical F-actin disassembly.
Calcium-induced secretion is greatly enhanced by constitutively active
mutants of Rho-related GTPases, V14RhoA and V12Rac1, and inhibited by a
specific Rho inhibitor, C3 transferase (4). It is relatively resistant
to inhibition of Rac by a dominant-inhibitory Rac protein, N17Rac1 (4).
Here, we have examined the role of Rho in calcium-dependent
secretion in relation to its cytoskeletal effects. Rho was found to
regulate both secretion and cortical F-actin disassembly in a manner
that is synergistic with and/or dependent on calcium but is
calmodulin-independent. The latter function of Rho is additional to and
distinct from the Rho-induced de novo actin polymerization
(which is calcium-independent). Stabilization of actin filaments by
high concentration of phalloidin prevented neither secretion nor the
secretion-enhancing effects of Rho, supporting the model for divergent
regulation of actin and exocytosis by this GTPase. This model is
further supported by a finding that compound Y-27632, a specific
inhibitor of Rho-associated protein kinase, p160ROCK,
attenuated the loss of cortical F-actin without affecting secretion.
 |
EXPERIMENTAL PROCEDURES |
GTP S and ATP were obtained from Roche Molecular Biochemicals.
Streptolysin-O was from Murex Diagnostics (Dartford, UK). Glass "Multitest" slides (6-mm diameter wells) were from ICN Biomedicals (Aurora, OH). Compound Y-27632 was a generous gift from Yoshitomi Pharmaceutical Industries, Ltd. All other reagents were obtained from Sigma.
Proteins
Escherichia coli transfected with expression vectors
containing GST-V14RhoA DNA, GST-V12Rac1 DNA or GST-C3 transferase DNA were kindly provided by Dr. Anne Ridley, and the glutathione
S-transferase fusion proteins were prepared and cleaved as
described (15) with minor modifications. V14RhoA was preactivated by
loading with GTP (16). The activated protein was stabilized by the
addition of MgCl2 to give a final Mg2+
concentration of 2 mM, dialyzed, and concentrated using the
Microsep 10-kDa cut-off centrifugal concentrators (Filtron, North
Borough, MA). This final dialysate was used for control experiments.
Active protein concentrations were determined by a filter binding assay using [3H]GDP (16). Concentrations of active proteins
(usually 60-70% of total) are given for all of the experiments.
Calmodulin was purified from bovine brain according to the protocol in
Ref. 17. The calmodulin-inhibitory peptide, MLCK peptide (MLCKP;
Ac-RRKWQKTGHAVRAIGRL-CONH2), and its control peptide (Ac-RRKEQKTGHAVRAIGRE-CONH2) (17)
were gifts from Dr. Kati Torok (School of Biological Sciences, Queen
Mary and Westfield College, University of London, UK).
Cells
Rat peritoneal mast cells were prepared as described previously
(18). The cells were resuspended in a solution containing 137 mM NaCl, 2.7 mM KCl, 1.0 mM
CaCl2, 2 mM MgCl2, 5.6 mM glucose, 1 mg ml 1 bovine serum albumin,
and 20 mM NaPIPES, pH 7.2 (chloride buffer). For confocal
microscopy, cells in chloride buffer were allowed to attach to glass
slides for 1 h at room temperature (~25,000 cells/well).
Suspended cells were used for flow cytometry and for hexosaminidase assays.
Suspended cells (usually 1-2 × 106 cells/ml) were
permeabilized for 2 min at 30 °C in a buffer containing 137 mM sodium glutamate, 2 mM MgCl2, 1 mg/ml bovine serum albumin, 20 mM NaPIPES, pH 6.8 (glutamate buffer (GB)) in the presence of 3 mM EGTA
(GB-EGTA) and streptolysin-O (0.4 units/ml). To permeabilize
glass-attached cells, the cells were washed with GB and then exposed
for 8 min at room temperature to streptolysin-O at 0.4 units/ml in
GB-EGTA. After permeabilization, both suspended and attached cells were washed free of soluble components and excess streptolysin-O with GB-EGTA. Cells were stimulated by the addition of the indicated combinations of calcium, EGTA, ATP, and GTP S. Free Ca2+
concentration was buffered by 3 mM Ca2+ EGTA
buffer system, pH 6.8, with appropriate dissociation constants as given
in Ref. 19. Control cells were exposed to 3 mM EGTA, 3 mM ATP in GB. Hexosaminidase release from at least
duplicate samples was assayed as described previously (18).
Where indicated, attached or suspended rat peritoneal mast cells were
permeabilized as above and pretreated with the specified agents
(phalloidin, C3 together with NAD+, or V14RhoA in the
GTP-bound form). While V14RhoA was left with the cells throughout the
experiment, C3 together with 0.5 mM NAD+ was
removed just prior to the addition of triggers.
Flow Cytometry
Identification of Secreting Cells--
Intact cells, suspended
in chloride buffer, were treated with unconjugated
succinyl-concanavalin A (100 µg/ml for 10 min at room temperature) to
reduce the background staining. Cells were then washed, permeabilized
as above, and exposed to 3 mM EGTA (control) or to the
triggers (20 min at 30 °C). The incubation was stopped by the
addition of cold GB, and the cells were pelletted by centrifugation (5 min at 1500 × g), resuspended in GB-EGTA containing
fluorescein isothiocyanate-succinyl-concanavalin A (64 µg/ml). After
20 min on ice, the stain was washed off (twice with GB-EGTA), and the
cells were finally resuspended (approximately 5 × 105
ml 1) in GB-EGTA containing 0.5% formaldehyde (without
any bovine serum albumin) and analyzed on an EPICS Elite flow cytometer
(Coulter Electronics Inc., Hialeah, FL), equipped with an argon ion
laser. Excitation was at 488 nm, and emission was at 525 nm. Forward angle (1.5-19°) and 90° light scatter and relative fluorescence intensity readings were collected. Freehand "gates" were drawn around subpopulations on two-parameter light scatter distributions using the Elite software, and the relative fluorescence intensity of
cells falling within these gates was plotted on one parameter histograms.
Staining with Rhodamine Phalloidin--
Staining with rhodamine
phalloidin (RP) was performed either before (prelabeling) or after
(postlabeling) cell activation.
Prelabeling--
Where indicated, suspended mast cells were
permeabilized and prelabeled with 0.1 µM RP in GB-EGTA
(10 min on ice). Cells were then washed with GB and exposed to various
triggering solutions for 20 min at 30 °C, quenched with cold GB,
fixed, and analyzed as above.
Postlabeling--
This was performed after the triggering and
the quenching of the cells but before their fixation: 0.5 µM RP in GB-EGTA, 20 min on ice.
Actin Filament Stabilization--
In some experiments (see Fig.
5B), cells were pretreated with 2 µM unlabeled
phalloidin in order to stabilize actin filaments, and this was followed
by postlabeling with 0.5 µM RP. After staining, cells
were washed with GB-EGTA, resuspended (approximately 5 × 105 ml 1) in GB-EGTA containing 0.5%
formaldehyde (without any bovine serum albumin), and analyzed on an
EPICS Elite flow cytometer (Coulter Electronics), equipped with an
argon ion laser. Excitation was at 488 nm, and emission was at 575 nm.
Fluorescence intensity of control cells (exposed to EGTA/ATP) was taken
as 100%. Means obtained from triplicate samples, each containing at
least 10,000 cells, are shown.
Confocal Microscopy and Image Analysis
Fluorescent images were obtained using a Leica confocal
laser-scanning microscope attached to a Leitz Fluovert-FU microscope. Excitation was at 514 nm, and emission was collected with a >600-nm barrier filter. Digital images (equatorial optical slices) were displayed using the Leica "glowovun" look-up table. Each experiment (in duplicates or triplicates) was repeated, and the results were reproduced at least three times.
A quantitative estimate of F-actin distribution changes was obtained by
radial line scan analysis of the images of the equatorial slices (13).
Three radial scan lines were obtained per cell, each extending from the
exterior to the center of the cell. To obtain the distribution plots,
as displayed in Fig. 4, A and B, the lines
obtained for each set of experimental conditions were averaged to form
a mean profile ± S.E. (n > 50; the statistic is
appropriate for the cell number and not the number of lines). For Fig.
4C, integration of areas under the traces from regions designated as cortical and internal (pixels 1-10 and 11-35,
respectively, representing 0-2.45 and 2.45-8.575 µm from the cell
edge) produced data that were then expressed in the form of a bar
chart. Changes in the cortical and internal regions were calculated as
percentages of the total F-actin content in both regions from
appropriate control cells (the sum of intensities of pixels 1-35 for
EGTA-treated cells). Thus, relative changes in distribution of F-actin
induced by calcium/ATP and/or V14RhoA could be evaluated.
Statistics
All figures shown are representative of at least three separate
experiments (levels of secretion vary greatly between individual experiments, but the effects are reproducible). Where error bars are
included, these are S.E. Where indicated, data were analyzed by
unpaired, one-tailed Student's t tests using
Instat® software. p values of <0.05 were taken
as significant and those of <0.002 as extremely significant.
 |
RESULTS |
After permeabilization, mast cells lose up to 70% of their total
actin. The remaining F-actin is present mostly in the cell periphery,
as a prominent subplasmalemmal network. Exposure of such permeabilized
cells to calcium (pCa < 6) and ATP ([ATP] > 1 mM),
induces a reduction of the cortical F-actin by 30-50%. Not all of the
cells exposed to calcium/ATP are capable of the secretory response; two
separate cell populations could be distinguished by flow cytometry
(using light scatter characteristics and/or fluorescein
isothiocyanate-succinyl-concanavalin A staining). Analysis of the
cytoskeletal responses of these two populations revealed that the
F-actin content of cells exposed to Ca/ATP is reduced in both secreting
and nonsecreting cells (as reflected by the rhodamine-phalloidin
fluorescence, not shown). Thus, F-actin loss occurs in both populations
and is not sufficient to induce secretion. Calmodulin plays a crucial
role in the calcium-induced loss of cortical F-actin; the latter is
promoted by the addition of exogenous calmodulin and strongly inhibited
by depletion of the endogenous calmodulin. None of these effects,
however, are accompanied by any changes in the secretory responses,
indicating that calmodulin is not required for the late steps in
exocytosis.2 The proportion of secreting cells is enhanced
by the addition of constitutively active mutants of both Rho (V14RhoA)
and Rac (V12Rac1) and inhibited by a Rho inhibitor, C3 transferase (4). The dominant inhibitory Rac protein, N17Rac1 does not have any significant effects on calcium-induced secretion (4). This paper
investigates whether the Rho-induced enhancement of secretion is
associated with any changes in the cytoskeletal responses.
Synergistic Effects of Calcium and Rho on
Secretion--
Synergistic effects of calcium and GTP/GTP S on
secretion from streptolysin-O-permeabilized rat peritoneal mast cells
are well established (12). To investigate whether Rho mimics GTP S in
this synergy, we have studied the effects of a constitutively active
mutant of Rho, V14RhoA, and of a Rho inhibitor, C3 transferase, on the
time course of and calcium requirements for secretion from suspended
permeabilized cells. Fig. 1A
shows that similarly to the effects of GTP S, V14RhoA eliminated the
delay in the onset of secretion, characteristic for the secretory
response of permeabilized mast cells to calcium (20). The extent of
hexosaminidase release was also enhanced by both GTP S and V14RhoA.
C3, on the other hand, was inhibitory. GTP S reduces calcium
requirements of permeabilized mast cells for secretion, and again,
similar effects were observed after the addition of V14RhoA (Fig.
1B). In contrast to GTP S, V14RhoA was unable to induce
secretion in the absence of calcium.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
V14RhoA abolishes the delay in the onset of
secretion and reduces calcium requirements. A,
permeabilized mast cells were pretreated for 5 min on ice with control
buffer, C3 (1 µg/ml) plus NAD+ (0.5 mM), or
with V14RhoA (8 µg/ml) and then triggered with calcium (pCa 5) plus 3 mM ATP ( , , ) or with calcium, 3 mM
ATP, 30 µM GTP S ( ) and incubated at 30 °C.
Aliquots were removed at the indicated time intervals for assay of the
released hexosaminidase. B, cells were treated as above and
then triggered with the indicated concentrations of calcium. All
figures are representative of three experiments. V14RhoA was
loaded with GTP and dialyzed. The final dialysate was used for the
control ( ).
|
|
Effects of Inhibiting Calmodulin and Rho--
To test whether the
effects of exogenous calmodulin require or are affected by the activity
of Rho, we have pretreated permeabilized mast cells with C3 transferase
prior to the addition of the exogenous calmodulin. The results are
shown in Fig. 2. The C3 pretreatment inhibited both F-actin disassembly (Fig. 2A) and secretion
(Fig. 2B). The sensitivity of the secretory response to C3
was, however, much greater than that of the cytoskeletal response.
Relative to the responses of control cells, C3 (at 1 µg/ml) caused
20 ± 3% inhibition of F-actin disassembly and 83 ± 5%
inhibition of secretion (n = 9). On the other hand,
exogenous calmodulin (at 12 µM, a concentration that
approximates its cytosolic level) had a marked effect on F-actin (Fig.
2A) without affecting secretion (Fig. 2B).
Calcium/calmodulin-induced F-actin disassembly was still inhibited by
C3, a small but a significant effect (Fig. 2A).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 2.
A and B, the effects of
calmodulin are apparent in the presence of C3, a Rho inhibitor.
Permeabilized mast cells in suspension were incubated with or without
C3 (1 µg/ml) plus 0.5 mM NAD+ (5 min on ice).
Cells were further preincubated with or without calmodulin (12 µM, 5 min on ice) and subsequently exposed to 3 mM EGTA plus 3 mM ATP or to calcium (pCa5) plus
3 mM ATP. After 20 min at 30 °C, aliquots were taken for
hexosaminidase release (B), and cells were stained
(postlabeled) with 0.5 µM RP, fixed, and analyzed by flow
cytometry for relative F-actin content (A). *,
p = 0.05; **, p = 0.005, both
significant. C and D, the effects of Rho are
apparent in the presence of MLCKP, a calmodulin inhibitor.
Permeabilized mast cells in suspension were preincubated (5 min on ice)
with calcium (pCa 6.5) and MLCKP (10 µM). Control cells
were treated with the control peptide (see "Experimental
Procedures"). Cells were further preincubated with or without V14RhoA
(8 µg/ml final concentration, 5 min at room temperature) and then
exposed to 3 mM EGTA plus 3 mM ATP or to
calcium (pCa 5) plus 3 mM ATP. After 20 min at 30 °C,
secretion (D) and F-actin content (C) were
analyzed as above. #, p = 0.002, extremely
significant.
|
|
To test whether the Rho-induced enhancement of both
calcium-dependent secretion and F-actin disassembly require
the presence of calmodulin, we have used permeabilized cells depleted
of this protein. Cells were pretreated with a calmodulin-inhibitory
peptide (MLCKP), a specific 17-residue peptide based on the
calmodulin-binding domain of myosin light chain kinase (17). Such
treatment depletes most of the endogenous calmodulin from the
permeabilized cells.2 Responses of these
calmodulin-depleted cells to calcium/ATP are shown in Fig. 2,
C and D. MLCKP treatment prevented F-actin
disassembly (Fig. 2C) but not secretion (Fig.
2D). Calmodulin-depleted cells were still responsive to the
addition of V14RhoA (8 µg/ml); in both control and MLCKP-treated
cells, V14RhoA enhanced calcium-induced secretion (Fig. 2D)
as well as F-actin loss (Fig. 2C). V14RhoA-induced enhancement of F-actin disassembly was, however, much smaller than that
induced by calmodulin (compare Fig. 2, compare A and C).
Synergistic Effects of Calcium and Rho on Cortical F-actin
Disassembly--
Previous studies of mast cells exposed to
GTP S/EGTA did not reveal any involvement of Rho in regulation of
cortical F-actin disassembly. Calcium-independent (i.e.
GTP S/EGTA-induced) cortical F-actin disassembly was neither
inhibited by C3 transferase nor stimulated by V14RhoA (13). The above
data suggest that Rho may control cortical filaments in a
calcium-dependent manner. To further examine the effects of
Rho on F-actin morphology, we have used confocal microscopy. Fig.
3 shows confocal micrographs of
glass-attached permeabilized cells stained with RP after their exposure
to EGTA or calcium (postlabeled). Fig. 4,
A and B, show line scan analyses of such images.
Control cells (exposed to EGTA) exhibit prominent cortical F-actin
(Fig. 3A). Figs. 3B and 4B show the
reduction of the cortical F-actin in cells exposed to calcium; the
effect of C3 transferase (inhibition of this loss of F-actin) is shown
in Fig. 3D. In the absence of calcium, V14RhoA induced
de novo actin polymerization in the cell interior and only a
very small reduction in the cortical F-actin (Figs. 3E and
4A). In the presence of calcium, however, Rho enhanced
cortical disassembly in addition to its effect on actin polymerization in the cell interior. This is shown in Figs. 3F and
4B. Fig. 4C shows a quantitative evaluation of
the V14RhoA-induced changes in distribution of F-actin, expressed in
the form of a bar chart. Relative changes in the
levels of F-actin in the cortical (full bars) and
the interior (hollow bars) regions are expressed
as percentages of the total F-actin content in both regions of the control cells. The effects of V14RhoA on cortical F-actin disassembly are thus synergistic with or dependent upon calcium, while those on
actin polymerization are calcium-independent.

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 3.
Effects of C3 and V14RhoA on F-actin
morphology. Glass-attached mast cells were permeabilized and
pretreated for 5 min on ice with control buffer (A and
B), 1 µg/ml C3 plus 0.5 mM NAD+
(C and D), or with V14RhoA (8 µg/ml)
(E and F). Cells were then stimulated with 3 mM EGTA plus 3 mM ATP (A,
C, and E) or calcium (pCa 5) plus 3 mM ATP (B, D, and F) for
20 min at 30 °C, fixed, and stained (postlabeled) with 0.5 µM rhodamine phalloidin to visualize F-actin.
Bar, 20 µm.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
Changes in the F-actin distribution induced
by V14RhoA in attached permeabilized mast cells. A and
B, glass-attached mast cells were permeabilized, pretreated
with ( ) or without ( and ) V14RhoA as described for Fig. 3,
E and F. Cells were then exposed to 3 mM EGTA plus 3 mM ATP (EA) or to
calcium (pCa 5) plus 3 mM ATP (CA) as indicated.
Densitometric line scan analyses were performed on confocal images
(equatorial slices) of the RP-stained cells (postlabeled).
Pixel distance is 0.245 µM. The intensity profiles of
these lines were pooled to form a mean profile ± S.E.
n = 50 cells. C, relative changes in
distribution of F-actin induced by V14RhoA. Changes in the levels of
F-actin in the cortical (solid bars) and the
interior (open bars) regions expressed as
percentages of the total F-actin content in both regions from control
cells.
|
|
Synergistic effects of V14RhoA and calcium on cortical F-actin
disassembly were confirmed by experiments with suspended cells, using
flow cytometry (Fig. 5A). For
this experiment, cells were prelabeled with a low concentration of RP
(0.1 µM) to determine the F-actin loss. This protocol
does not interfere with the cytoskeletal responses of activated cells
and avoids detection of any new filaments polymerized after cell
activation (13). The addition of V14RhoA to permeabilized mast cells
prior to and during their exposure to Ca/ATP significantly enhanced
the extent of cortical F-actin disassembly (left) as well as
that of secretion (right). On the other hand, V14RhoA caused
neither disassembly nor secretion in the absence of calcium
(i.e. in 3 mM EGTA, not shown).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
A, Rho enhances calcium-induced cortical
F-actin disassembly and secretion. Permeabilized mast cells were
suspended in GB and prelabeled for 5 min on ice with 0.1 µM RP, followed by a further pretreatment with or without
V14RhoA (8 µg/ml). Cells were then exposed to 3 mM EGTA
plus 3 mM ATP (open bars) or to
calcium (pCa 5) plus 3 mM ATP (solid
bars) and incubated for 20 min at 30 °C. Relative F-actin
content was determined by flow cytometry (left
panel), and secretion was determined by hexosaminidase assay
(right panel). B, Rho induces de
novo actin polymerization and enhances secretion in cells with
stabilized actin cortex. Cells were pretreated as above with 2 µM unlabeled phalloidin with or without V14RhoA (8 µg/ml) and then exposed to 3 mM EGTA plus 3 mM ATP or to calcium (pCa 5) plus 3 mM ATP (20 min at 30 °C). Cells were then postlabeled with 0.5 µM
RP and fixed. Secretion and F-actin were determined as above. Secretion
from the cells with stabilized actin was the same as that from control
cells (not pretreated with phalloidin).
|
|
Stabilization of Cortical F-actin by Phalloidin Does Not Prevent
Secretion-enhancing Effects of Rho--
Experiments with permeabilized
mast cells, pretreated with increasing concentrations of unlabeled
phalloidin, have shown that calcium-induced cortical actin disassembly
is prevented at concentrations of phalloidin >1.5 µM.
Secretion, however, was unaffected by these higher concentrations of
phalloidin (not shown). We have used a similar protocol to investigate
whether the secretion-enhancing effects of V14Rho are dependent on its
disassembly-enhancing effects (Fig. 5B). Cells were
pretreated with 2 µM (unlabeled) phalloidin to stabilize
the filaments and to prevent calcium-induced disassembly. After the
exposure to calcium, cells were stained with RP to reveal any newly
polymerized filaments. It is clear that F-actin cortex stabilization
did not affect the ability of V14RhoA to enhance secretion (Fig.
5B, right). The increase in F-actin content,
apparent after the addition of V14RhoA, is the result of
V14RhoA-induced de novo polymerization of actin
(left).
p160ROCK Inhibitor Attenuates Rho-induced Enhancement
of Cortical F-actin Disassembly--
One of the downstream targets of
Rho is a Rho-associated protein kinase, p160ROCK. This enzyme
was found to phosphorylate and so inactivate the myosin-binding subunit
of myosin light chain phosphatase, leading to an increase in the level
of phosphorylated myosin II light chain (MLC) (21). To test whether
cortical F-actin disassembly is regulated by Rho as a result of Rho
controlling actomyosin-based contractility, we have used compound
Y-27632, a specific p160ROCK inhibitor (22). Fig.
6A shows that Y-27632 had no
effect on calcium-induced secretion and did not prevent its enhancement by V14RhoA. On the other hand, the Y compound had a marginal inhibitory effect on the calcium-induced cortical F-actin disassembly and caused a
significant reduction of its V14RhoA-induced enhancement (Fig.
6B). Compound Y-27632 had no effects on de novo
actin polymerization (not shown).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 6.
Y-27632 inhibits Rho-induced enhancement of
cortical actin disassembly. Suspended mast cells were
permeabilized, washed, and prelabeled with 0.1 µM RP for
5 min on ice. After washing, cells were further incubated for 5 min on
ice with control buffer (con), 1 µg·ml 1 C3
and 0.5 mM NAD+ (+C3), 30 µM compound Y-27632 (+Y), 8 µg·ml 1 V14RhoA (+Rho), or 30 µM compound Y-27632 for 3 min followed by 8 µg·ml 1 V14RhoA for 2 min (+Y/+Rho). Cells
were then triggered with calcium (pCa 5) plus 3 mM ATP for
20 min at 30 °C, keeping the concentrations of added agents
constant. Supernatant aliquots were taken for determination of released
hexosaminidase (A), and cells were analyzed by flow
cytometry for relative F-actin content (B). Basal cells
(exposed to 3 mM EGTA plus 3 mM ATP) released
4% hexosaminidase, and their F-actin content was taken as 100%. The
Y-compound, C3, and V14RhoA had no effect on secretion or total F-actin
content of basal cells (i.e. in 3 mM EGTA plus 3 mM MgATP, not shown). **, p = 0.0002 (extremely significant).
|
|
 |
DISCUSSION |
Calcium-independent Effects of Rho: De Novo Actin
Polymerization--
In the absence of calcium, GTP S induces low
levels of secretion that can be partially inhibited by a Rho inhibitor,
C3 transferase, and only slightly stimulated by the addition of the
constitutively active mutant of Rho, V14RhoA (4). The addition of
V14RhoA/EGTA to permeabilized mast cells does not, however, induce
secretion (Fig. 1), indicating that in the absence of calcium,
activation of Rho is not a sufficient trigger.
GTP S/EGTA also induces two cytoskeletal effects: de novo
actin polymerization and cortical F-actin disassembly (4, 13). The
former effect is completely inhibited by C3. Moreover, V14RhoA mimics
this effect, inducing actin polymerization independently of calcium
(Figs. 3E and 4A). Cytochalasin inhibits this
localized increase in F-actin without affecting secretion (23).
Although there is a clear correlation between actin polymerization and secretion, their control by Rho appears to proceed via two divergent signaling pathways. Since most of the soluble monomeric actin leaks out
from the permeabilized cells, Rho seems to control recruitment of actin
from a membrane-bound pool of actin monomers. Our evidence for the
Rho-induced polymerization of actin contrasts with that of Machesky and
Hall (24). These authors concluded that Rho bundles actin filaments but
does not induce polymerization; monomeric Cy3-labeled actin,
microinjected into Swiss 3T3 fibroblasts, was incorporated into
lamellipodia, induced by activation of Rac, but not into stress fibers
formed after Rho activation. This discrepancy could be explained by the
existence of the suggested membrane-bound pool of monomeric actin from
which Rho recruits monomers and in which Cy3-actin would not be included.
GTP S/EGTA-induced cortical F-actin disassembly is not significantly
affected by C3 and thus seems to be independent of Rho activity.
V14RhoA/EGTA does not induce F-actin loss (Figs. 3E and
4A). This effect of GTP S can be mimicked by
AlF4 , an activator of heterotrimeric
G-proteins (13). Our preliminary results indicate that GTP S/EGTA
induces cortical F-actin disassembly via a Gi protein; the
loss of F-actin is inhibited by pertussis toxin.3
Calcium-dependent Effects of Rho on
Secretion--
Calcium/ATP-induced secretion is strongly inhibited by
C3 transferase, implicating Rho in this response (4). While in the absence of calcium, V14RhoA was unable to mimic the effects of GTP S
on secretion, it had a strong secretion-enhancing effect in its
presence (Figs. 1, 2D, 5, and 6A). V14RhoA
reduced the requirements of permeabilized cells for calcium (Fig.
1B) and abolished the delay in the onset of calcium-induced
secretion. The rate-limiting step of calcium-induced secretion may
therefore be a calcium-induced activation of the endogenous Rho. This
could occur via calcium-sensitive Rho-GTPase-activating proteins (such as IQGAP (25, 26) or class IX myosins (27)) or via calcium-sensitive guanine nucleotide exchange factors (such as Vav (28) or those similar
to guanine nucleotide-releasing factor for Ras, Ras-GRF (29)) (see
X in the model, Fig. 7).
Alternatively, calcium and ATP could work together to maintain GTP
levels by transphosphorylating the endogenous GDP (as discussed in Ref.
20) and also included under X in the model, Fig. 7). Another
explanation of the synergy with or the dependence upon calcium could be
the existence of parallel signaling pathways from Rho and calcium that
converge and act on a common target (see Y in the model,
Fig. 7).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 7.
The model. Rho-related GTPases play a
key role in mast cell exocytosis, converging onto a putative component
Y, which may control fusion of the plasma and granular membranes
(independently of calmodulin). Rho is activated by a calcium-sensitive
protein X, also in a calmodulin-independent manner. Protein X may be
the calcium-binding protein, Ce, previously postulated to
activate a GTPase required for exocytosis, Ge (35). Calcium
may also activate Y independently of Rho, but in a synergistic manner.
Both calmodulin/MLCK and Rho/Rho kinase induce actomyosin II-based
contractility, which is crucial for disassembly of the actin cortex but
not for secretion. Disassembly of the contracting cortex is aided by
calcium-dependent activation of filament-severing proteins
(14) and inhibition of filament-cross-linkers (36). In addition, Rho
and Rac (independently of secretion) promote an increase in F-actin
within the cell interior: Rho by inducing de novo actin
polymerization and Rac by retaining the disassembling cortical
filaments (13).
|
|
Calcium-dependent Effects of Rho on Cortical F-actin
Disassembly--
In addition to controlling secretion and actin
polymerization, Rho was found to have an additional role, that of
promoting cortical F-actin disassembly. This role became apparent only
in the presence of calcium: C3 transferase inhibited and V14RhoA promoted calcium-induced F-actin loss. The control of F-actin disassembly by Rho is, however, only partial. At 1 µg/ml, C3
inhibited secretion by ~80%, while the disassembly was inhibited by
only 20%. Another, Rho-independent, pathway to calcium-induced
cortical F-actin disassembly must therefore exist. Our recent data
point to the MLCK pathway: calcium-induced F-actin loss is greatly
promoted by exogenous calmodulin and strongly inhibited by 1)
calmodulin antagonists; 2) ML-7, a specific inhibitor of MLCK; and 3)
2,3-butanedione 2-monoxime, an uncompetitive, low affinity inhibitor of
myosin MgATPase).2 Rho and calmodulin seem to act
independently of each other, since the calmodulin effect on cortical
disassembly was still apparent in the presence of C3 transferase (Fig.
2A). Moreover, V14RhoA could induce a small but significant
decrease in F-actin content in calmodulin-depleted cells (Fig.
2C).
Rho and calcium/calmodulin may control cortical actin disassembly by
pathways that converge on myosin II light chain (see the model, Fig.
7). One of the targets of Rho, the Rho-associated protein kinase
p160ROCK, is involved in the control of myosin II light chain
phosphorylation. This kinase phosphorylates the myosin-binding subunit
of myosin light chain phosphatase, decreasing its activity (21). In
addition, the myosin-binding subunit of MLC phosphatase binds to Rho
directly (21). A further level of complexity is added by the finding that Rho kinase also phosphorylates MLC on Ser-19, the same site as
that phosphorylated by MLCK (30). Compound Y-27632, a specific p160ROCK inhibitor (22), had a negligible effect on
calcium-induced F-actin disassembly but significantly reduced its
enhancement by V14RhoA (Fig. 6B). This suggests that
p160ROCK participates in the regulation of actin cortex, but
other targets of Rho may also be involved. Taken together, our data
indicate that cortical F-actin disassembly is dependent on
actomyosin-based contractility. Both calmodulin and Rho may induce an
increase in MLC phosphorylation, leading to an increase in myosin
activity and contractility. Calmodulin/MLCK-dependent,
rather than Rho-dependent process, however, constitutes the
major pathway to F-actin disassembly (see Fig. 7).
Relevance of the Cortical F-actin Disassembly to
Secretion--
The relevance of the cortical F-actin disassembly to
secretion is still somewhat controversial. Prevention of F-actin
disassembly by phalloidin does not affect either the secretion or
secretion-enhancing effects of Rho (Fig. 5B). Moreover,
agents other than phalloidin (e.g. inhibitors of calmodulin
and MLCK) also stabilize cortical filaments without affecting secretion
(Fig. 2D).2
F-actin disassembly itself is not sufficient for secretion to occur: it
is induced by calcium/ATP in both secreting and nonsecreting cell
populations. An additional (presumably Rho/Rac-dependent) signal must, therefore, be necessary to initiate exocytosis. Thus, our
results support a model with divergent signaling pathways to the
cytoskeleton and to the late steps of exocytosis (23). It is
conceivable, however, that a great part of the observed cytoskeletal
changes is physiologically relevant for responses of intact cells
exposed to concentration gradients of stimuli: under such conditions,
cell polarization and motility may play a crucial role before
exocytosis is initiated. Moreover, stabilization of F-actin by
jasplakinolide, a cell-permeant actin-specific agent (31), inhibits
secretion in intact, but not in permeabilized, cells.4 This
suggests actin involvement in the receptor activation-secretion coupling.
In permeabilized cells, manipulation of the actin cytoskeleton by
actin-binding proteins such as thymosin (32) or scinderin (33) induces
changes in secretory responses. In mast cells, late steps of exocytosis
were affected as a consequence of filament severing by gelsolin (14).
Whether this effect is related to the finding that gelsolin is a
downstream effector of Rac (34) remains to be established. Different
specific pools of actin may be involved, controlling distinct steps of
exocytosis. For example, a pool of filaments, closely associated with
the plasma membrane and severed by exogenous gelsolin, may constitute a
barrier to secretion. In contrast, those filaments that are more
peripheral to the plasma membrane and undergo disassembly as a
consequence of contraction do not appear to interfere with secretion.
Our results are compatible with a model in which myosin-based
contractility, activated by Rho and/or calcium/calmodulin, is required
for the cortical F-actin disassembly, but this type of disassembly is not required for the late steps of exocytosis. Fig. 7 summarizes the
evidence and shows our current model.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Kati Torok for providing the
calmodulin-inhibitory peptide and Yoshitomi Pharmaceutical Industries,
Ltd. for supplying the compound Y-27632. We especially thank Dr. Anne
Ridley for providing the E. coli, transfected with V14RhoA
and C3 transferase, and for helpful discussions. We also acknowledge
Prof. S. Bolsover who kindly allowed the use of his confocal
microscope, purchased with funds from the Wellcome Trust; Arnold Pitzey
for generous help with the EPICS Elite flow cytometer; and Prof. J. Judah for support and encouragement.
 |
FOOTNOTES |
*
This work was supported by grants from the Medical Research
Council, the Wellcome Trust, the National Asthma Campaign, and the
Mason Medical Research Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Merck (UK) Research & Development, Harrier House,
West Drayton, Middlesex UB7 7QG, United Kingdom.
§
Present address: Div. of Cell Biology, The Netherlands Cancer
Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
¶
To whom correspondence should be addressed: Physiology Dept.,
University College London, University St., London WC1E 6JJ, United
Kingdom. Tel.: 44-171-2096094; Fax: 44-171-3876368; E-mail: a.koffer@ucl.ac.uk.
2
R. Sullivan, M. Burnham, and A. Koffer,
submitted for publication.
3
R. Sullivan and A. Koffer, unpublished observations.
4
R. Sullivan and A. Koffer, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
GTP S, guanosine
5'-3-O-(thio)triphosphate;
MLC, myosin light chain;
MLCK, myosin light chain kinase;
MLCKP, MLCK peptide;
piperazine-N, N'-bis(2-ethanesulfonic acid;
GB, glutamate buffer;
RP, rhodamine phalloidin.
 |
REFERENCES |
| 1.
|
Takai, Y.,
Sasaki, T.,
Tanaka, K.,
and Nakanishi, H.
(1995)
Trends Biochem. Sci.
20,
227-231[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Tapon, N.,
and Hall, A.
(1997)
Curr. Opin. Cell Biol.
9,
86-92[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Vojtek, A. B.,
and Cooper, J. A.
(1995)
Cell
82,
527-529[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Price, L. S.,
Norman, J. C.,
Ridley, A. J.,
and Koffer, A.
(1995)
Curr. Biol.
5,
68-73[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Schmalzing, G.,
Richter, H. P.,
Hansen, A.,
Schwarz, W.,
Just, I.,
and Aktories, K.
(1995)
J. Cell Biol.
130,
1319-1332[Abstract/Free Full Text]
|
| 6.
|
Lamaze, C.,
Chuang, T. H.,
Terlecky, L. J.,
Bokoch, G. M.,
and Schmid, S. L.
(1996)
Nature
382,
177-179[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Murphy, C.,
Saffrich, R.,
Grummt, M.,
Gournier, H.,
Rybin, V.,
Rubino, M.,
Auvinen, P.,
Lutcke, A.,
Parton, R. G.,
and Zerial, M.
(1996)
Nature
384,
427-432[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Guillemot, J. C.,
Montcourrier, P.,
Vivier, E.,
Davoust, J.,
and Chavrier, P.
(1997)
J. Cell Sci.
110,
215-2225
|
| 9.
|
Brown, A. M.,
O'Sullivan, A. J.,
and Gomperts, B. D.
(1998)
Mol. Biol. Cell
9,
1053-1063[Abstract/Free Full Text]
|
| 10.
|
Burgoyne, R. D.,
and Cheek, T. R.
(1985)
Biosci. Rep.
7,
281-288
|
| 11.
|
Pfeiffer, J. R.,
Seagrave, J. C.,
Davis, B. H.,
Deanin, G. G.,
and Oliver, J. M.
(1985)
J. Cell Biol.
101,
2145-2155[Abstract/Free Full Text]
|
| 12.
|
Howell, T. W.,
Cockcroft, S.,
and Gomperts, B. D.
(1987)
J. Cell Biol.
105,
191-197[Abstract/Free Full Text]
|
| 13.
|
Norman, J. C.,
Price, L. S.,
Ridley, A. J.,
Hall, A.,
and Koffer, A.
(1994)
J. Cell Biol.
126,
1005-1015[Abstract/Free Full Text]
|
| 14.
|
Borovikov, Y. S.,
Norman, J. C.,
Price, L. S.,
Weeds, A.,
and Koffer, A.
(1995)
J. Cell Sci.
108,
657-666[Abstract]
|
| 15.
|
Ridley, A. J.,
and Hall, A.
(1992)
Cell
70,
389-399[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Hall, A.,
and Self, A. J.
(1986)
J. Biol. Chem.
261,
10963-10965[Abstract/Free Full Text]
|
| 17.
|
Torok, K.,
and Trentham, D. R.
(1994)
Biochemistry
33,
12807-12820[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Cockcroft, S.,
Howell, T. W.,
and Gomperts, B. D.
(1987)
J. Cell Biol.
105,
2745-2750[Abstract/Free Full Text]
|
| 19.
|
Martell, A. E.,
and Smith, R. M.
(1974)
Critical Stability Constants
, p. XI-XII, Plenum Press, New York
|
| 20.
|
Koffer, A.
(1993)
Biochim. Biophys. Acta
1176,
236-244
|
| 21.
|
Kimura, K.,
Ito, M.,
Amano, M.,
Chihara, K.,
Fukata, Y.,
Nakafuku, M.,
Yamamori, B.,
Feng, J.,
Nakano, T.,
Okawa, K.,
Iwamatsu, A.,
and Kaibuchi, K.
(1996)
Science
273,
245-248[Abstract]
|
| 22.
|
Uehata, M.,
Ishizaki, T.,
Satoh, H.,
Ono, T.,
Kawahara, T.,
Morishita, T.,
Tamakawa, H.,
Yamagami, K.,
Inui, J.,
Maekawa, M.,
and Narumiya, S.
(1997)
Nature
389,
990-994[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Norman, J. C.,
Price, L. S.,
Ridley, A. J.,
and Koffer, A.
(1996)
Mol. Biol. Cell
7,
1429-1442[Abstract]
|
| 24.
|
Machesky, L. M.,
and Hall, A.
(1997)
J. Cell Biol.
138,
913-926[Abstract/Free Full Text]
|
| 25.
|
Hart, M. J.,
Callow, M. G.,
Souza, B.,
and Polakis, P.
(1996)
EMBO J.
15,
2997-3005[Medline]
[Order article via Infotrieve]
|
| 26.
|
Brill, S.,
Li, S.,
Lyman, C. W.,
Church, D. M.,
Wasmuth, J. J.,
Weissbach, L.,
Bernards, A.,
and Snijders, A. J.
(1996)
Mol. Cell. Biol.
16,
4869-4878[Abstract]
|
| 27.
|
Reinhard, J.,
Scheel, A. A.,
Diekmann, D.,
Hall, A.,
Ruppert, C.,
and Bahler, M.
(1995)
EMBO J.
14,
697-704[Medline]
[Order article via Infotrieve]
|
| 28.
|
Castresana, J.,
and Saraste, M.
(1995)
FEBS Lett.
374,
149-151[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Freshney, N. W.,
Goonesekera, S. D.,
and Feig, L. A.
(1997)
FEBS Lett.
407,
111-115[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Amano, M.,
Ito, M.,
Kimura, K.,
Fukata, Y.,
Chihara, K.,
Nakano, T.,
Matsuura, Y.,
and Kaibuchi, K.
(1996)
J. Biol. Chem.
271,
20246-20249[Abstract/Free Full Text]
|
| 31.
|
Bubb, M. R.,
Senderowicz, A. M.,
Sausville, E. A.,
Duncan, K. L.,
and Korn, E. D.
(1994)
J. Biol. Chem.
269,
14869-14871[Abstract/Free Full Text]
|
| 32.
|
Muallem, S.,
Kwiatkowska, K.,
Xu, X.,
and Yin, H. L.
(1995)
J. Cell Biol.
128,
589-598[Abstract/Free Full Text]
|
| 33.
|
Zhang, L.,
Marcu, M. G.,
Nau Staudt, K.,
and Trifaro, J. M.
(1996)
Neuron
17,
287-296[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Azuma, T.,
Witke, W.,
Stossel, T. P.,
Hartwig, J. H.,
and Kwiatkowski, D. J.
(1998)
EMBO J.
17,
1362-1370[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Lillie, T. H.,
and Gomperts, B. D.
(1992)
Biochem. J.
288,
181-187
|
| 36.
|
Harris, A. S.,
and Morrow, J. S.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
3009-3013[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. W. Moore, J. P. Correia, K. Lai Wing Sun, M. Pool, A. E. Fournier, and T. E. Kennedy
Rho inhibition recruits DCC to the neuronal plasma membrane and enhances axon chemoattraction to netrin 1
Development,
September 1, 2008;
135(17):
2855 - 2864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Bi and J. A. Williams
A role for Rho and Rac in secretagogue-induced amylase release by pancreatic acini
Am J Physiol Cell Physiol,
July 1, 2005;
289(1):
C22 - C32.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Oka, M. Hori, and H. Ozaki
Microtubule Disruption Suppresses Allergic Response through the Inhibition of Calcium Influx in the Mast Cell Degranulation Pathway
J. Immunol.,
April 15, 2005;
174(8):
4584 - 4589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, K. L. O'Connor, M. R. Hellmich, G. H. Greeley Jr., C. M. Townsend Jr., and B. M. Evers
The Role of Protein Kinase D in Neurotensin Secretion Mediated by Protein Kinase C-{alpha}/-{delta} and Rho/Rho Kinase
J. Biol. Chem.,
July 2, 2004;
279(27):
28466 - 28474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Vitale and M. E. Carbajal
Involvement of Myosin II in Dopamine-induced Reorganization of the Lactotroph Cell's Actin Cytoskeleton
J. Histochem. Cytochem.,
April 1, 2004;
52(4):
517 - 527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Oka, M. Hori, A. Tanaka, H. Matsuda, H. Karaki, and H. Ozaki
IgE alone-induced actin assembly modifies calcium signaling and degranulation in RBL-2H3 mast cells
Am J Physiol Cell Physiol,
February 1, 2004;
286(2):
C256 - C263.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Gasman, S. Chasserot-Golaz, M. Malacombe, M. Way, and M.-F. Bader
Regulated Exocytosis in Neuroendocrine Cells: A Role for Subplasmalemmal Cdc42/N-WASP-induced Actin Filaments
Mol. Biol. Cell,
February 1, 2004;
15(2):
520 - 531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Lecuona, K. Ridge, L. Pesce, D. Batlle, and J. I. Sznajder
The GTP-binding Protein RhoA Mediates Na,K-ATPase Exocytosis in Alveolar Epithelial Cells
Mol. Biol. Cell,
September 1, 2003;
14(9):
3888 - 3897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pendleton, B. Pope, A. Weeds, and A. Koffer
Latrunculin B or ATP Depletion Induces Cofilin-dependent Translocation of Actin into Nuclei of Mast Cells
J. Biol. Chem.,
April 11, 2003;
278(16):
14394 - 14400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Klarenbach, A. Chipiuk, R. C. Nelson, M. D. Hollenberg, and A. G. Murray
Differential Actions of PAR2 and PAR1 in Stimulating Human Endothelial Cell Exocytosis and Permeability: The Role of Rho-GTPases
Circ. Res.,
February 21, 2003;
92(3):
272 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. W. Kang, S. J. Lee, J. W. Park, and S. G. Kim
Phosphatidylinositol 3-Kinase Regulates Nuclear Translocation of NF-E2-Related Factor 2 through Actin Rearrangement in Response to Oxidative Stress
Mol. Pharmacol.,
November 1, 2002;
62(5):
1001 - 1010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. van Leeuwen, G. Elliott, and P. O'Hare
Evidence of a Role for Nonmuscle Myosin II in Herpes Simplex Virus Type 1 Egress
J. Virol.,
March 7, 2002;
76(7):
3471 - 3481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Adachi, R. Vita, S. Sannohe, S. Stafford, R. Alam, H. Kayaba, and J. Chihara
The Functional Role of Rho and Rho-Associated Coiled-Coil Forming Protein Kinase in Eotaxin Signaling of Eosinophils
J. Immunol.,
October 15, 2001;
167(8):
4609 - 4615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ishizuka, F. Okajima, M. Ishiwara, K. Iizuka, I. Ichimonji, T. Kawata, H. Tsukagoshi, K. Dobashi, T. Nakazawa, and M. Mori
Sensitized Mast Cells Migrate Toward the Agen: A Response Regulated by p38 Mitogen-Activated Protein Kinase and Rho-Associated Coiled-Coil-Forming Protein Kinase
J. Immunol.,
August 15, 2001;
167(4):
2298 - 2304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Togo, T. B. Krasieva, and R. A. Steinhardt
A Decrease in Membrane Tension Precedes Successful Cell-Membrane Repair
Mol. Biol. Cell,
December 1, 2000;
11(12):
4339 - 4346.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Glogauer, J. Hartwig, and T. Stossel
Two Pathways Through Cdc42 Couple the N-formyl Receptor to Actin Nucleation in Permeabilized Human Neutrophils
J. Cell Biol.,
August 21, 2000;
150(4):
785 - 796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Buxton and R. S. Adelstein
Calcium-dependent Threonine Phosphorylation of Nonmuscle Myosin in Stimulated RBL-2H3 Mast Cells
J. Biol. Chem.,
October 27, 2000;
275(44):
34772 - 34779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ales, N. H. Gabilan, M. F. Cano-Abad, A. G. Garcia, and M. G. Lopez
The Sea Anemone Toxin Bc2 Induces Continuous or Transient Exocytosis, in the Presence of Sustained Levels of High Cytosolic Ca2+ in Chromaffin Cells
J. Biol. Chem.,
November 22, 2000;
275(48):
37488 - 37495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Klussmann, G. Tamma, D. Lorenz, B. Wiesner, K. Maric, F. Hofmann, K. Aktories, G. Valenti, and W. Rosenthal
An Inhibitory Role of Rho in the Vasopressin-mediated Translocation of Aquaporin-2 into Cell Membranes of Renal Principal Cells
J. Biol. Chem.,
June 1, 2001;
276(23):
20451 - 20457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tamma, E. Klussmann, K. Maric, K. Aktories, M. Svelto, W. Rosenthal, and G. Valenti
Rho inhibits cAMP-induced translocation of aquaporin-2 into the apical membrane of renal cells
Am J Physiol Renal Physiol,
December 1, 2001;
281(6):
F1092 - F1101.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|